A species of PLASMODIUM causing malaria in rodents.
A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.
A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics.
A genus of protozoa that comprise the malaria parasites of mammals. Four species infect humans (although occasional infections with primate malarias may occur). These are PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE, and PLASMODIUM VIVAX. Species causing infection in vertebrates other than man include: PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; P. vinckei, and PLASMODIUM YOELII in rodents; P. brasilianum, PLASMODIUM CYNOMOLGI; and PLASMODIUM KNOWLESI in monkeys; and PLASMODIUM GALLINACEUM in chickens.
A protozoan parasite of rodents transmitted by the mosquito Anopheles dureni.
Vaccines made from antigens arising from any of the four strains of Plasmodium which cause malaria in humans, or from P. berghei which causes malaria in rodents.
Proteins found in any species of protozoan.
The product of meiotic division of zygotes in parasitic protozoa comprising haploid cells. These infective cells invade the host and undergo asexual reproduction producing MEROZOITES (or other forms) and ultimately gametocytes.
A protozoan parasite that causes vivax malaria (MALARIA, VIVAX). This species is found almost everywhere malaria is endemic and is the only one that has a range extending into the temperate regions.
Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered.
Immunoglobulins produced in a response to PROTOZOAN ANTIGENS.
A surface protein found on Plasmodium species which induces a T-cell response. The antigen is polymorphic, sharing amino acid sequence homology among PLASMODIUM FALCIPARUM; PLASMODIUM CHABAUDI; PLASMODIUM VIVAX; and PLASMODIUM YOELII.
The presence of parasites (especially malarial parasites) in the blood. (Dorland, 27th ed)
Inbred BALB/c mice are a strain of laboratory mice that have been selectively bred to be genetically identical to each other, making them useful for scientific research and experiments due to their consistent genetic background and predictable responses to various stimuli or treatments.
Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN.
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)
A protozoan parasite of rodents transmitted by the mosquito Anopheles stephensi.
Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations.
A genus of mosquitoes (CULICIDAE) that are known vectors of MALARIA.
The functional hereditary units of protozoa.
The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
A protozoan parasite from Southeast Asia that causes monkey malaria. It is naturally acquired by man in Malaysia and can also be transmitted experimentally to humans.
The complete genetic complement contained in a set of CHROMOSOMES in a protozoan.
A protozoan parasite that occurs primarily in subtropical and temperate areas. It is the causal agent of quartan malaria. As the parasite grows it exhibits little ameboid activity.
Deoxyribonucleic acid that makes up the genetic material of protozoa.
Uninuclear cells or a stage in the life cycle of sporozoan protozoa. Merozoites, released from ruptured multinucleate SCHIZONTS, enter the blood stream and infect the ERYTHROCYTES.
The continuous sequence of changes undergone by living organisms during the post-embryonic developmental process, such as metamorphosis in insects and amphibians. This includes the developmental stages of apicomplexans such as the malarial parasite, PLASMODIUM FALCIPARUM.
Malaria caused by PLASMODIUM VIVAX. This form of malaria is less severe than MALARIA, FALCIPARUM, but there is a higher probability for relapses to occur. Febrile paroxysms often occur every other day.
Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER).
Liver diseases caused by infections with PARASITES, such as tapeworms (CESTODA) and flukes (TREMATODA).
The relationship between an invertebrate and another organism (the host), one of which lives at the expense of the other. Traditionally excluded from definition of parasites are pathogenic BACTERIA; FUNGI; VIRUSES; and PLANTS; though they may live parasitically.
A species of protozoan parasite causing MALARIA. It is the rarest of the four species of PLASMODIUM infecting humans, but is common in West African countries and neighboring areas.
Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow).
Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified.
Bites and stings inflicted by insects.
A plant genus of the family AMARANTHACEAE, order Caryophyllales, which has been used in traditional medicine (MEDICINE, CHINESE TRADITIONAL).
Inbred C57BL mice are a strain of laboratory mice that have been produced by many generations of brother-sister matings, resulting in a high degree of genetic uniformity and homozygosity, making them widely used for biomedical research, including studies on genetics, immunology, cancer, and neuroscience.
Antigenic determinants recognized and bound by the B-cell receptor. Epitopes recognized by the B-cell receptor are located on the surface of the antigen.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Insects that transmit infective organisms from one host to another or from an inanimate reservoir to an animate host.
The classes of immunoglobulins found in any species of animal. In man there are nine classes that migrate in five different groups in electrophoresis; they each consist of two light and two heavy protein chains, and each group has distinguishing structural and functional properties.
An encapsulated lymphatic organ through which venous blood filters.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration.
A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.
A protozoan parasite that occurs naturally in the macaque. It is similar to PLASMODIUM VIVAX and produces a type of malaria similar to vivax malaria (MALARIA, VIVAX). This species has been found to give rise to both natural and experimental human infections.
Diseases of rodents of the order RODENTIA. This term includes diseases of Sciuridae (squirrels), Geomyidae (gophers), Heteromyidae (pouched mice), Castoridae (beavers), Cricetidae (rats and mice), Muridae (Old World rats and mice), Erethizontidae (porcupines), and Caviidae (guinea pigs).
Multinucleate cells or a stage in the development of sporozoan protozoa. It is exemplified by the life cycle of PLASMODIUM FALCIPARUM in the MALARIA infection cycle.
The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
A protozoan parasite that causes avian malaria (MALARIA, AVIAN), primarily in chickens, and is transmitted by the Aedes mosquito.
Tests that demonstrate the relative effectiveness of chemotherapeutic agents against specific parasites.

Induction of CD8+ T cell-mediated protective immunity against Trypanosoma cruzi. (1/438)

Trypanosoma cruzi was transformed with the Plasmodium yoelii gene encoding the circum-sporozoite (CS) protein, which contains the well-characterized CD8+ T cell epitope, SYVPSAEQI. In vivo and in vitro assays indicated that cells infected with the transformed T. cruzi could process and present this malaria parasite-derived class I MHC-restricted epitope. Immunization of mice with recombinant influenza and vaccinia viruses expressing the SYVPSAEQI epitope induced a large number of specific CD8+ T cells that strongly suppressed parasitemia and conferred complete protection against the acute T. cruzi lethal infection. CD8+ T cells mediated this immunity as indicated by the unrelenting parasitemia and high mortality observed in immunized mice treated with anti-CD8 antibody. This study demonstrated, for the first time, that vaccination of mice with vectors designed to induce CD8+ T cells is effective against T. cruzi infection.  (+info)

Factors associated with the development of neonatal tolerance after the administration of a plasmid DNA vaccine. (2/438)

A plasmid DNA vaccine encoding the circumsporozoite protein of malaria (pCSP) induces tolerance rather than immunity when administered to newborn mice. We find that this tolerance persists for >1 yr after neonatal pCSP administration and interferes with the induction of protective immunity in animals challenged with live sporozoites. Susceptibility to tolerance induction wanes rapidly with age, disappearing within 1 wk of birth. Higher doses of plasmid are more tolerogenic, and susceptibility to tolerance is not MHC-restricted. CD8+ T cells from tolerant mice suppress the in vitro Ag-specific immune response of cells from adult mice immunized with pCSP. Similarly, CD8+ T cells from tolerant mice transfer nonresponsiveness to naive syngeneic recipients. These findings clarify the cellular basis and factors contributing to the development of DNA vaccine-induced neonatal tolerance.  (+info)

Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains. (3/438)

The 19 kDa carboxy-terminal domain of Plasmodium yoelii merozoite surface protein-1 (MSP1(19)) was expressed in Salmonella vaccine strains as a carboxy-terminal fusion to fragment C of tetanus toxin (TetC). This study demonstrates that antibodies that recognize disulphide-dependent conformational epitopes in native MSP1 react with the TetC-MSP1(19) fusion protein expressed in Salmonella. The proper folding of MSP1(19) polypeptide is dependent on both the Salmonella host strain and the protein to which the MSP1(19) polypeptide is fused. Serum from mice immunized with Salmonella typhimurium C5aroD expressing TetC-MSP1(19) recognized native MSP1 as shown by immunofluorescence with P. yoelii-infected erythrocytes. Antibody levels to MSP1(19) were highest in out-bred mice immunized with S. typhimurium C5aroD carrying pTECH2-MSP1(19) and antibody was mostly directed against reduction-sensitive conformational epitopes. However, antibody levels were lower than in BALB/c mice immunized with a glutathione S-transferase (GST)-MSP1(19) fusion protein in Freund's adjuvant, and which were protected against P. yoelii challenge infection. In challenge experiments with P. yoelii the Salmonella-immunized mice were not protected, probably reflecting the magnitude of the antibody response. The results of this study have important implications in the design of live multivalent bacterial vaccines against eukaryotic pathogens.  (+info)

Glutathione-S-transferase activity in malarial parasites. (4/438)

Glutathione-S-transferase (GST) activity has been detected in rodent (Plasmodium berghei, P. yoelii), simian (P. knowlesi) and human (P. falciparum) malarial parasites, and in different intraerythrocytic stages of P. knowlesi (schizont > ring > trophozoite). In chloroquine-resistant strains of rodent and human malarial parasites GST activity significantly increases compared to sensitive strains. Further, the increase in enzyme activity is directly related to drug pressure of resistant P. berghei. Complete inhibition of chloroquine-sensitive and resistant P. berghei glutathione-S-transferase activities was observed at 2.5 and 5. micrometer concentration of hemin, respectively. An inverse relationship was found between the heme level and enzyme activity of chloroquine-resistant and sensitive P. berghei. Chloroquine, artemisinin, and primaquine noticeably inhibited GST activity in P. knowlesi.  (+info)

A mechanism for the synergistic antimalarial action of atovaquone and proguanil. (5/438)

A combination of atovaquone and proguanil has been found to be quite effective in treating malaria, with little evidence of the emergence of resistance when atovaquone was used as a single agent. We have examined possible mechanisms for the synergy between these two drugs. While proguanil by itself had no effect on electron transport or mitochondrial membrane potential (DeltaPsim), it significantly enhanced the ability of atovaquone to collapse DeltaPsim when used in combination. This enhancement was observed at pharmacologically achievable doses. Proguanil acted as a biguanide rather than as its metabolite cycloguanil (a parasite dihydrofolate reductase [DHFR] inhibitor) to enhance the atovaquone effect; another DHFR inhibitor, pyrimethamine, also had no enhancing effect. Proguanil-mediated enhancement was specific for atovaquone, since the effects of other mitochondrial electron transport inhibitors, such as myxothiazole and antimycin, were not altered by inclusion of proguanil. Surprisingly, proguanil did not enhance the ability of atovaquone to inhibit mitochondrial electron transport in malaria parasites. These results suggest that proguanil in its prodrug form acts in synergy with atovaquone by lowering the effective concentration at which atovaquone collapses DeltaPsim in malaria parasites. This could explain the paradoxical success of the atovaquone-proguanil combination even in regions where proguanil alone is ineffective due to resistance. The results also suggest that the atovaquone-proguanil combination may act as a site-specific uncoupler of parasite mitochondria in a selective manner.  (+info)

Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1. (6/438)

Vaccination of mice with the leading malaria vaccine candidate homologue, the 19-kDa carboxyl terminus of merozoite surface protein-1 (MSP119), results in sterile immunity to Plasmodium yoelii, with no parasites detected in blood. Although such immunity depends upon high titer Abs at challenge, high doses of immune sera transferred into naive mice reduce parasitemia (and protect from death) but do not result in a similar degree of protection (with most mice experiencing high peak parasitemias); this finding suggests that ongoing parasite-specific immune responses postchallenge are essential. We analyzed this postchallenge response by transferring Abs into manipulated but malaria-naive mice and observed that Abs cannot protect SCID, nude, CD4+ T cell-depleted, or B cell knockout mice, with all mice dying. Thus, in addition to the Abs that develop following MSP119 vaccination, a continuing active immune response postchallenge is required for protection. MSP119-specific Abs can adoptively transfer protection to strains of mice that are not protected following vaccination with MSP119, suggesting that the Ags targeted by the immune response postchallenge include Ags apart from MSP119. These data have important implications for the development of a human malaria vaccine.  (+info)

Effects of nitroquine on ultrastructures and cytochrome oxidase of exoerythrocytic Plasmodium yoelii in rat liver. (7/438)

AIM: To study the effects of nitroquine acetate (NA) on the ultrastructures and cytochrome-c oxidase (CCO) of exoerythrocytic forms (EEF) of Plasmodium yoelii. METHODS: Rats were inoculated with sporozoites directly into the liver. After 48 h rats were killed. Rat liver thin sections were incubated in histochemical reaction medium, then examined by transmission electron microscopy. NA (2 mg.kg-1) was fed to rats 3.5 h and 14 h before killing the rats. RESULTS: At 3.5 h, in the parasites there appeared swelling and proliferation of mitochondria, dilation of endoplasmic reticulum, and reduction of the electron density of parasites' nuclei. The structures of the parasites disintegrated to form many autophagocytes 14 h after exposure to NA. The reaction products of CCO still existed until 14 h after using NA. CONCLUSION: CCO was not the starting point of NA action. NA interferes with the structure and function of the cytoplasm and nucleus of malaria parasites and exerts its antimalarial effects in many aspects.  (+info)

Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite. (8/438)

Endoperoxide antimalarials based on the ancient Chinese drug Qinghaosu (artemisinin) are currently our major hope in the fight against drug-resistant malaria. Rational drug design based on artemisinin and its analogues is slow as the mechanism of action of these antimalarials is not clear. Here we report that these drugs, at least in part, exert their effect by interfering with the plasmodial hemoglobin catabolic pathway and inhibition of heme polymerization. In an in vitro experiment we observed inhibition of digestive vacuole proteolytic activity of malarial parasite by artemisinin. These observations were further confirmed by ex vivo experiments showing accumulation of hemoglobin in the parasites treated with artemisinin, suggesting inhibition of hemoglobin degradation. We found artemisinin to be a potent inhibitor of heme polymerization activity mediated by Plasmodium yoelii lysates as well as Plasmodium falciparum histidine-rich protein II. Interaction of artemisinin with the purified malarial hemozoin in vitro resulted in the concentration-dependent breakdown of the malaria pigment. Our results presented here may explain the selective and rapid toxicity of these drugs on mature, hemozoin-containing, stages of malarial parasite. Since artemisinin and its analogues appear to have similar molecular targets as chloroquine despite having different structures, they can potentially bypass the quinoline resistance machinery of the malarial parasite, which causes sublethal accumulation of these drugs in resistant strains.  (+info)

'Plasmodium yoelii' is a species of protozoan parasite belonging to the genus Plasmodium, which causes malaria in rodents. It is primarily used as a model organism in malaria research due to its similarity to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax. The life cycle of P. yoelii involves two hosts: an Anopheles mosquito vector and a rodent host. The parasite undergoes asexual reproduction in the red blood cells of the rodent host, leading to the symptoms of malaria such as fever, anemia, and organ failure if left untreated. P. yoelii is not known to infect humans.

Malaria is not a medical definition itself, but it is a disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. Here's a simple definition:

Malaria: A mosquito-borne infectious disease caused by Plasmodium parasites, characterized by cycles of fever, chills, and anemia. It can be fatal if not promptly diagnosed and treated. The five Plasmodium species known to cause malaria in humans are P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi.

'Plasmodium falciparum' is a specific species of protozoan parasite that causes malaria in humans. It is transmitted through the bites of infected female Anopheles mosquitoes and has a complex life cycle involving both human and mosquito hosts.

In the human host, the parasites infect red blood cells, where they multiply and cause damage, leading to symptoms such as fever, chills, anemia, and in severe cases, organ failure and death. 'Plasmodium falciparum' malaria is often more severe and life-threatening than other forms of malaria caused by different Plasmodium species. It is a major public health concern, particularly in tropical and subtropical regions of the world where access to prevention, diagnosis, and treatment remains limited.

"Plasmodium" is a genus of protozoan parasites that are the causative agents of malaria in humans and other animals. There are several species within this genus, including Plasmodium falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi, among others.

These parasites have a complex life cycle that involves two hosts: an Anopheles mosquito and a vertebrate host (such as humans). When a person is bitten by an infected mosquito, the parasites enter the bloodstream and infect red blood cells, where they multiply and cause the symptoms of malaria.

Plasmodium species are transmitted through the bites of infected female Anopheles mosquitoes, which become infected after taking a blood meal from an infected person. The parasites then develop in the mosquito's midgut, eventually making their way to the salivary glands, where they can be transmitted to another human through the mosquito's bite.

Malaria is a serious and sometimes fatal disease that affects millions of people worldwide, particularly in tropical and subtropical regions. It is characterized by fever, chills, headache, muscle and joint pain, and anemia, among other symptoms. Prompt diagnosis and treatment are essential to prevent severe illness and death from malaria.

"Plasmodium berghei" is a species of protozoan parasites belonging to the genus Plasmodium, which are the causative agents of malaria. This particular species primarily infects rodents and is not known to naturally infect humans. However, it is widely used in laboratory settings as a model organism to study malaria and develop potential interventions, such as drugs and vaccines, due to its similarities with human-infecting Plasmodium species.

The life cycle of P. berghei involves two hosts: an Anopheles mosquito vector and a rodent host. The parasite undergoes asexual reproduction in the red blood cells of the rodent host, leading to the symptoms of malaria, such as fever, anemia, and organ damage. When an infected mosquito bites another rodent, the parasites are transmitted through the saliva and infect the new host, continuing the life cycle.

While P. berghei is not a direct threat to human health, studying this species has contributed significantly to our understanding of malaria biology and the development of potential interventions against this devastating disease.

Malaria vaccines are biological preparations that induce immunity against malaria parasites, thereby preventing or reducing the severity of malaria disease. They typically contain antigens (proteins or other molecules derived from the parasite) that stimulate an immune response in the recipient, enabling their body to recognize and neutralize the pathogen upon exposure.

The most advanced malaria vaccine candidate is RTS,S/AS01 (Mosquirix), which targets the Plasmodium falciparum parasite's circumsporozoite protein (CSP). This vaccine has shown partial protection in clinical trials, reducing the risk of severe malaria and hospitalization in young children by about 30% over four years. However, it does not provide complete immunity, and additional research is ongoing to develop more effective vaccines against malaria.

I'm sorry for any confusion, but "Protozoan Proteins" is not a specific medical or scientific term. Protozoa are single-celled eukaryotic organisms, and proteins are large biological molecules consisting of one or more chains of amino acid residues. Therefore, "Protozoan Proteins" generally refers to the various types of proteins found in protozoa.

However, if you're looking for information about proteins specific to certain protozoan parasites with medical relevance (such as Plasmodium falciparum, which causes malaria), I would be happy to help! Please provide more context or specify the particular protozoan of interest.

Sporozoites are a stage in the life cycle of certain parasitic protozoans, including Plasmodium species that cause malaria. They are infective forms that result from the sporulation of oocysts, which are produced in the vector's midgut after the ingestion of gametocytes during a blood meal.

Once mature, sporozoites are released from the oocyst and migrate to the salivary glands of the vector, where they get injected into the host during subsequent feedings. In the host, sporozoites infect liver cells, multiply within them, and eventually rupture the cells, releasing merozoites that invade red blood cells and initiate the erythrocytic stage of the parasite's life cycle.

Sporozoites are typically highly motile and possess a unique gliding motility, which enables them to traverse various host tissues during their invasion process. This invasive ability is facilitated by an actin-myosin motor system and secretory organelles called micronemes and rhoptries, which release adhesive proteins that interact with host cell receptors.

In summary, sporozoites are a crucial stage in the life cycle of Plasmodium parasites, serving as the infective forms responsible for transmitting malaria between hosts via an insect vector.

"Plasmodium vivax" is a species of protozoan parasite that causes malaria in humans. It's one of the five malaria parasites that can infect humans, with P. falciparum being the most deadly.

P. vivax typically enters the human body through the bite of an infected Anopheles mosquito. Once inside the human host, the parasite travels to the liver where it multiplies and matures. After a period of development that can range from weeks to several months, the mature parasites are released into the bloodstream, where they infect red blood cells and continue to multiply.

The symptoms of P. vivax malaria include fever, chills, headache, muscle and joint pain, and fatigue. One distinctive feature of P. vivax is its ability to form dormant stages (hypnozoites) in the liver, which can reactivate and cause relapses of the disease months or even years after the initial infection.

P. vivax malaria is treatable with medications such as chloroquine, but resistance to this drug has been reported in some parts of the world. Prevention measures include using insecticide-treated bed nets and indoor residual spraying to reduce mosquito populations, as well as taking prophylactic medications for travelers visiting areas where malaria is common.

Antigens are substances (usually proteins) found on the surface of cells, or viruses, that can be recognized by the immune system and stimulate an immune response. In the context of protozoa, antigens refer to the specific proteins or other molecules found on the surface of these single-celled organisms that can trigger an immune response in a host organism.

Protozoa are a group of microscopic eukaryotic organisms that include a diverse range of species, some of which can cause diseases in humans and animals. When a protozoan infects a host, the host's immune system recognizes the protozoan antigens as foreign and mounts an immune response to eliminate the infection. This response involves the activation of various types of immune cells, such as T-cells and B-cells, which recognize and target the protozoan antigens.

Understanding the nature of protozoan antigens is important for developing vaccines and other immunotherapies to prevent or treat protozoan infections. For example, researchers have identified specific antigens on the surface of the malaria parasite that are recognized by the human immune system and have used this information to develop vaccine candidates. However, many protozoan infections remain difficult to prevent or treat, and further research is needed to identify new targets for vaccines and therapies.

Antibodies, protozoan, refer to the immune system's response to an infection caused by a protozoan organism. Protozoa are single-celled microorganisms that can cause various diseases in humans, such as malaria, giardiasis, and toxoplasmosis.

When the body is infected with a protozoan, the immune system responds by producing specific proteins called antibodies. Antibodies are produced by a type of white blood cell called a B-cell, and they recognize and bind to specific antigens on the surface of the protozoan organism.

There are five main types of antibodies: IgA, IgD, IgE, IgG, and IgM. Each type of antibody has a different role in the immune response. For example, IgG is the most common type of antibody and provides long-term immunity to previously encountered pathogens. IgM is the first antibody produced in response to an infection and is important for activating the complement system, which helps to destroy the protozoan organism.

Overall, the production of antibodies against protozoan organisms is a critical part of the immune response and helps to protect the body from further infection.

Merozoite Surface Protein 1 (MSP1) is a malarial antigen, which is a protein present on the surface of merozoites, which are the invasive forms of the Plasmodium parasites that cause malaria. MSP1 plays a crucial role in the invasion of red blood cells by the merozoites during the erythrocytic stage of the parasite's life cycle.

The MSP1 protein is synthesized and processed through several stages, resulting in multiple fragments, including the C-terminal 42 kDa fragment (MSP1-42) that is further cleaved into four smaller fragments (MSP1-19, MSP1-33, MSP1-38, and MSP1-42). These fragments are involved in the recognition and attachment of merozoites to the red blood cells, followed by the formation of a tight junction between the parasite and the host cell membranes.

MSP1 is one of the most abundant and immunogenic proteins on the surface of the merozoites, making it an attractive vaccine candidate. However, despite extensive research, a successful MSP1-based malaria vaccine has yet to be developed due to challenges in eliciting a protective immune response against this complex antigen.

Parasitemia is a medical term that refers to the presence of parasites, particularly malaria-causing Plasmodium species, in the bloodstream. It is the condition where red blood cells are infected by these parasites, which can lead to various symptoms such as fever, chills, anemia, and organ damage in severe cases. The level of parasitemia is often used to assess the severity of malaria infection and to guide treatment decisions.

BALB/c is an inbred strain of laboratory mouse that is widely used in biomedical research. The strain was developed at the Institute of Cancer Research in London by Henry Baldwin and his colleagues in the 1920s, and it has since become one of the most commonly used inbred strains in the world.

BALB/c mice are characterized by their black coat color, which is determined by a recessive allele at the tyrosinase locus. They are also known for their docile and friendly temperament, making them easy to handle and work with in the laboratory.

One of the key features of BALB/c mice that makes them useful for research is their susceptibility to certain types of tumors and immune responses. For example, they are highly susceptible to developing mammary tumors, which can be induced by chemical carcinogens or viral infection. They also have a strong Th2-biased immune response, which makes them useful models for studying allergic diseases and asthma.

BALB/c mice are also commonly used in studies of genetics, neuroscience, behavior, and infectious diseases. Because they are an inbred strain, they have a uniform genetic background, which makes it easier to control for genetic factors in experiments. Additionally, because they have been bred in the laboratory for many generations, they are highly standardized and reproducible, making them ideal subjects for scientific research.

Erythrocytes, also known as red blood cells (RBCs), are the most common type of blood cell in circulating blood in mammals. They are responsible for transporting oxygen from the lungs to the body's tissues and carbon dioxide from the tissues to the lungs.

Erythrocytes are formed in the bone marrow and have a biconcave shape, which allows them to fold and bend easily as they pass through narrow blood vessels. They do not have a nucleus or mitochondria, which makes them more flexible but also limits their ability to reproduce or repair themselves.

In humans, erythrocytes are typically disc-shaped and measure about 7 micrometers in diameter. They contain the protein hemoglobin, which binds to oxygen and gives blood its red color. The lifespan of an erythrocyte is approximately 120 days, after which it is broken down in the liver and spleen.

Abnormalities in erythrocyte count or function can lead to various medical conditions, such as anemia, polycythemia, and sickle cell disease.

Antimalarials are a class of drugs that are used for the prevention, treatment, and elimination of malaria. They work by targeting the malaria parasite at various stages of its life cycle, particularly the erythrocytic stage when it infects red blood cells. Some commonly prescribed antimalarials include chloroquine, hydroxychloroquine, quinine, mefloquine, and artemisinin-based combinations. These drugs can be used alone or in combination with other antimalarial agents to increase their efficacy and prevent the development of drug resistance. Antimalarials are also being investigated for their potential use in treating other diseases, such as autoimmune disorders and cancer.

"Plasmodium chabaudi" is a species of parasitic protozoa belonging to the genus Plasmodium, which includes the causative agents of malaria in various animals and humans. "P. chabaudi" primarily infects rodents, particularly mice, and serves as a model organism for studying the fundamental biology and pathogenesis of malaria.

The life cycle of "P. chabaudi" involves both sexual and asexual reproduction, similar to other Plasmodium species. The parasite is transmitted through the bite of an infected Anopheles mosquito, which injects sporozoites into the host's bloodstream. These sporozoites then infect liver cells, where they undergo schizogony (asexual reproduction) and produce merozoites.

Merozoites released from the liver invade red blood cells, initiating the erythrocytic stage of the life cycle. Within the red blood cells, the parasites multiply by schizogony, forming new merozoites that are eventually released to infect other red blood cells. Some of these parasites differentiate into male and female gametocytes, which can be taken up by a mosquito during a blood meal, completing the life cycle.

"P. chabaudi" infections in mice can lead to various pathological changes, including anemia, splenomegaly (enlarged spleen), and immune responses that contribute to disease progression. Researchers use this model organism to investigate aspects of malaria biology, such as host-parasite interactions, immunity, drug development, and vaccine design.

Malaria, Falciparum is defined as a severe and often fatal form of malaria caused by the parasite Plasmodium falciparum. It is transmitted to humans through the bites of infected Anopheles mosquitoes. This type of malaria is characterized by high fever, chills, headache, muscle and joint pain, and vomiting. If left untreated, it can cause severe anemia, kidney failure, seizures, coma, and even death. It is a major public health problem in many tropical and subtropical regions of the world, particularly in Africa.

'Anopheles' is a genus of mosquitoes that are known for their role in transmitting malaria parasites to humans. These mosquitoes have a distinctive resting posture, with their abdomens raised and heads down, and they typically feed on human hosts at night. Only female Anopheles mosquitoes transmit the malaria parasite, as they require blood meals to lay eggs.

There are over 400 species of Anopheles mosquitoes worldwide, but only about 30-40 of these are considered significant vectors of human malaria. The distribution and behavior of these mosquitoes can vary widely depending on the specific species and geographic location.

Preventing and controlling the spread of malaria involves a variety of strategies, including the use of insecticide-treated bed nets, indoor residual spraying, antimalarial drugs, and vaccines. Public health efforts to reduce the burden of malaria have made significant progress in recent decades, but the disease remains a major global health challenge, particularly in sub-Saharan Africa.

Genes in protozoa refer to the hereditary units of these single-celled organisms that carry genetic information necessary for their growth, development, and reproduction. These genes are made up of DNA (deoxyribonucleic acid) molecules, which contain sequences of nucleotide bases that code for specific proteins or RNA molecules. Protozoan genes are responsible for various functions, such as metabolism, response to environmental stimuli, and reproduction.

It is important to note that the study of protozoan genes has contributed significantly to our understanding of genetics and evolution, particularly in areas such as molecular biology, cell biology, and genomics. However, there is still much to be learned about the genetic diversity and complexity of these organisms, which continue to be an active area of research.

Chloroquine is an antimalarial and autoimmune disease drug. It works by increasing the pH or making the environment less acidic in the digestive vacuoles of malaria parasites, which inhibits the polymerization of heme and the formation of hemozoin. This results in the accumulation of toxic levels of heme that are harmful to the parasite. Chloroquine is also used as an anti-inflammatory agent in the treatment of rheumatoid arthritis, discoid or systemic lupus erythematosus, and photodermatitis.

The chemical name for chloroquine is 7-chloro-4-(4-diethylamino-1-methylbutylamino)quinoline, and it has a molecular formula of C18H26ClN3. It is available in the form of phosphate or sulfate salts for oral administration as tablets or solution.

Chloroquine was first synthesized in 1934 by Bayer scientists, and it has been widely used since the 1940s as a safe and effective antimalarial drug. However, the emergence of chloroquine-resistant strains of malaria parasites has limited its use in some areas. Chloroquine is also being investigated for its potential therapeutic effects on various viral infections, including COVID-19.

"Plasmodium knowlesi" is a species of protozoan parasite that causes malaria in certain primates, particularly macaques. It can also infect humans, and has been identified as a significant cause of malaria in Southeast Asia. The life cycle of P. knowlesi involves two hosts: anopheline mosquitoes and primates. The parasite is transmitted to the host through the bite of an infected mosquito, and then invades and reproduces within the host's red blood cells, leading to symptoms such as fever, chills, headache, and muscle and joint pain. In severe cases, P. knowlesi infections can lead to complications such as respiratory distress, kidney failure, and coma.

It is important to note that "Plasmodium knowlesi" malaria is different from the more common forms of human malaria caused by Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae. P. knowlesi infections can be effectively treated with antimalarial drugs, but early diagnosis and prompt treatment are crucial to prevent severe disease and complications.

A protozoan genome refers to the complete set of genetic material or DNA present in a protozoan organism. Protozoa are single-celled eukaryotic microorganisms that lack cell walls and have diverse morphology and nutrition modes. The genome of a protozoan includes all the genes that code for proteins, as well as non-coding DNA sequences that regulate gene expression and other cellular processes.

The size and complexity of protozoan genomes can vary widely depending on the species. Some protozoa have small genomes with only a few thousand genes, while others have larger genomes with tens of thousands of genes or more. The genome sequencing of various protozoan species has provided valuable insights into their evolutionary history, biology, and potential as model organisms for studying eukaryotic cellular processes.

It is worth noting that the study of protozoan genomics is still an active area of research, and new discoveries are continually being made about the genetic diversity and complexity of these fascinating microorganisms.

"Plasmodium malariae" is a species of protozoan parasite that causes malaria in humans. It's one of the five Plasmodium species known to cause malaria in humans, with the other four being P. falciparum, P. vivax, P. ovale, and P. knowlesi.

P. malariae is transmitted through the bites of infected Anopheles mosquitoes. Once inside the human body, the parasites travel to the liver where they multiply and then infect red blood cells. The infection caused by P. malariae can persist for several years, even a lifetime, if not treated properly.

The symptoms of P. malariae infection include fever, chills, headache, muscle and joint pain, and anemia. However, the severity of these symptoms is generally less than that caused by P. falciparum, which is the most deadly form of malaria.

It's worth noting that while P. malariae can be effectively treated with antimalarial drugs such as chloroquine and primaquine, drug resistance has been reported in some areas, making accurate diagnosis and treatment even more critical for controlling the spread of this disease.

There doesn't seem to be a specific medical definition for "DNA, protozoan" as it is simply a reference to the DNA found in protozoa. Protozoa are single-celled eukaryotic organisms that can be found in various environments such as soil, water, and the digestive tracts of animals.

Protozoan DNA refers to the genetic material present in these organisms. It is composed of nucleic acids, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), which contain the instructions for the development, growth, and reproduction of the protozoan.

The DNA in protozoa, like in other organisms, is made up of two strands of nucleotides that coil together to form a double helix. The four nucleotide bases that make up protozoan DNA are adenine (A), thymine (T), guanine (G), and cytosine (C). These bases pair with each other to form the rungs of the DNA ladder, with A always pairing with T and G always pairing with C.

The genetic information stored in protozoan DNA is encoded in the sequence of these nucleotide bases. This information is used to synthesize proteins, which are essential for the structure and function of the organism's cells. Protozoan DNA also contains other types of genetic material, such as regulatory sequences that control gene expression and repetitive elements with no known function.

Understanding the DNA of protozoa is important for studying their biology, evolution, and pathogenicity. It can help researchers develop new treatments for protozoan diseases and gain insights into the fundamental principles of genetics and cellular function.

Merozoites are infective forms of certain protozoan parasites, including those that cause malaria. They are produced during the asexual reproduction of these parasites within the red blood cells of their hosts. Merozoites are released from the infected red blood cells when they rupture and can then invade other red blood cells to continue the cycle of infection. These organisms have an outer membrane that allows them to interact with and invade host cells, and they contain proteins on their surface that help them evade the host's immune system. Merozoites are typically small, oval-shaped structures that measure around 1 micrometer in diameter.

'Life cycle stages' is a term used in the context of public health and medicine to describe the different stages that an organism goes through during its lifetime. This concept is particularly important in the field of epidemiology, where understanding the life cycle stages of infectious agents (such as bacteria, viruses, parasites) can help inform strategies for disease prevention and control.

The life cycle stages of an infectious agent may include various forms such as spores, cysts, trophozoites, schizonts, or vectors, among others, depending on the specific organism. Each stage may have different characteristics, such as resistance to environmental factors, susceptibility to drugs, and ability to transmit infection.

For example, the life cycle stages of the malaria parasite include sporozoites (the infective form transmitted by mosquitoes), merozoites (the form that infects red blood cells), trophozoites (the feeding stage inside red blood cells), schizonts (the replicating stage inside red blood cells), and gametocytes (the sexual stage that can be taken up by mosquitoes to continue the life cycle).

Understanding the life cycle stages of an infectious agent is critical for developing effective interventions, such as vaccines, drugs, or other control measures. For example, targeting a specific life cycle stage with a drug may prevent transmission or reduce the severity of disease. Similarly, designing a vaccine to elicit immunity against a particular life cycle stage may provide protection against infection or disease.

Malaria, Vivax:

A type of malaria caused by the parasite Plasmodium vivax. It is transmitted to humans through the bites of infected Anopheles mosquitoes. Malaria, Vivax is characterized by recurring fevers, chills, and flu-like symptoms, which can occur every other day or every third day. This type of malaria can have mild to severe symptoms and can sometimes lead to complications such as anemia and splenomegaly (enlarged spleen). One distinguishing feature of Malaria, Vivax is its ability to form dormant stages in the liver (called hypnozoites), which can reactivate and cause relapses even after years of apparent cure. Effective treatment includes medication to kill both the blood and liver stages of the parasite. Preventive measures include using mosquito nets, insect repellents, and antimalarial drugs for prophylaxis in areas with high transmission rates.

Passive immunization is a type of temporary immunity that is transferred to an individual through the injection of antibodies produced outside of the body, rather than through the active production of antibodies in the body in response to vaccination or infection. This can be done through the administration of preformed antibodies, such as immune globulins, which contain a mixture of antibodies that provide immediate protection against specific diseases.

Passive immunization is often used in situations where individuals have been exposed to a disease and do not have time to develop their own active immune response, or in cases where individuals are unable to produce an adequate immune response due to certain medical conditions. It can also be used as a short-term measure to provide protection until an individual can receive a vaccination that will confer long-term immunity.

Passive immunization provides immediate protection against disease, but the protection is typically short-lived, lasting only a few weeks or months. This is because the transferred antibodies are gradually broken down and eliminated by the body over time. In contrast, active immunization confers long-term immunity through the production of memory cells that can mount a rapid and effective immune response upon re-exposure to the same pathogen in the future.

Parasitic liver diseases refer to conditions caused by protozoa or helminths (parasitic worms) that infect and damage the liver. These parasites can enter the body through contaminated food, water, or direct contact with an infected host. Some examples of parasitic liver diseases include:

1. Ascariasis: Caused by the roundworm Ascaris lumbricoides, which can infect the liver and bile ducts, leading to inflammation, obstruction, and abscess formation.
2. Echinococcosis (Hydatid disease): A rare but serious condition caused by the larval stage of tapeworms from the genus Echinococcus. The liver is the most commonly affected organ, with cysts forming in the liver parenchyma that can grow slowly over several years and cause complications such as rupture or secondary bacterial infection.
3. Fascioliasis: A foodborne trematode (fluke) infection caused by Fasciola hepatica or Fasciola gigantica, which affects the liver and bile ducts. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
4. Leishmaniasis: A protozoan infection caused by Leishmania spp., which can affect various organs, including the liver. Visceral leishmaniasis (kala-azar) is the most severe form of the disease, characterized by hepatosplenomegaly, fever, and anemia.
5. Toxoplasmosis: A protozoan infection caused by Toxoplasma gondii, which can affect the liver and other organs. While most immunocompetent individuals remain asymptomatic or experience mild flu-like symptoms, immunocompromised patients are at risk of severe liver damage and disseminated disease.
6. Schistosomiasis: A trematode (fluke) infection caused by Schistosoma spp., which affects the liver and portal venous system. The parasites lay eggs in the liver, causing granulomatous inflammation, fibrosis, and portal hypertension.
7. Fasciolopsiasis: A trematode (fluke) infection caused by Fasciolopsis buski, which affects the small intestine and liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
8. Paragonimiasis: A trematode (lung fluke) infection caused by Paragonimus spp., which can affect the lungs, brain, and other organs, including the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
9. Clonorchiasis: A trematode (liver fluke) infection caused by Clonorchis sinensis, which affects the bile ducts and liver. The parasites lay eggs in the bile ducts, causing inflammation, cholangitis, and cholangiocarcinoma.
10. Opisthorchiasis: A trematode (liver fluke) infection caused by Opisthorchis spp., which affects the bile ducts and liver. The parasites lay eggs in the bile ducts, causing inflammation, cholangitis, and cholangiocarcinoma.
11. Heterophyiasis: A trematode (intestinal fluke) infection caused by Heterophyes spp., which affects the small intestine and liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
12. Metagonimiasis: A trematode (intestinal fluke) infection caused by Metagonimus spp., which affects the small intestine and liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
13. Echinostomiasis: A trematode (intestinal fluke) infection caused by Echinostoma spp., which affects the small intestine and liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
14. Gastrodiscoidiasis: A trematode (intestinal fluke) infection caused by Gastrodiscoides spp., which affects the large intestine and liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
15. Fascioliasis: A trematode (liver fluke) infection caused by Fasciola spp., which affects the liver and bile ducts. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
16. Paragonimiasis: A trematode (lung fluke) infection caused by Paragonimus spp., which affects the lungs and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
17. Schistosomiasis: A trematode (blood fluke) infection caused by Schistosoma spp., which affects the blood vessels and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
18. Clonorchiasis: A trematode (liver fluke) infection caused by Clonorchis sinensis, which affects the liver and bile ducts. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
19. Opisthorchiasis: A trematode (liver fluke) infection caused by Opisthorchis spp., which affects the liver and bile ducts. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
20. Metagonimiasis: A trematode (intestinal fluke) infection caused by Metagonimus spp., which affects the small intestine and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
21. Heterophyesiasis: A trematode (intestinal fluke) infection caused by Heterophyes spp., which affects the small intestine and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
22. Echinostomiasis: A trematode (intestinal fluke) infection caused by Echinostoma spp., which affects the small intestine and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
23. Fasciolopsiasis: A trematode (intestinal fluke) infection caused by Fasciolopsis buski, which affects the small intestine and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
24. Paragonimiasis: A trematode (lung fluke) infection caused by Paragonimus spp., which affects the lungs and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
25. Spirometra mansoni: A trematode (tapeworm) infection caused by Spirometra mansoni, which affects the brain and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
26. Taenia solium: A trematode (tapeworm) infection caused by Taenia solium, which affects the brain and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
27. Hymenolepis nana: A trematode (tapeworm) infection caused by Hymenolepis nana, which affects the small intestine and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
28. Diphyllobothrium latum: A trematode (tapeworm) infection caused by Diphyllobothrium latum, which affects the small intestine and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
29. Echinococcus granulosus:

Host-parasite interactions refer to the relationship between a parasitic organism (the parasite) and its host, which can be an animal, plant, or human body. The parasite lives on or inside the host and derives nutrients from it, often causing harm in the process. This interaction can range from relatively benign to severe, depending on various factors such as the species of the parasite, the immune response of the host, and the duration of infection.

The host-parasite relationship is often categorized based on the degree of harm caused to the host. Parasites that cause little to no harm are called commensals, while those that cause significant damage or disease are called parasitic pathogens. Some parasites can even manipulate their hosts' behavior and physiology to enhance their own survival and reproduction, leading to complex interactions between the two organisms.

Understanding host-parasite interactions is crucial for developing effective strategies to prevent and treat parasitic infections, as well as for understanding the ecological relationships between different species in natural ecosystems.

"Plasmodium ovale" is a species of protozoan parasites that are transmitted to humans through the bites of infected female Anopheles mosquitoes. This parasite causes a type of malaria known as "ovale malaria," which is generally milder than other forms of malaria caused by Plasmodium falciparum or Plasmodium vivax.

The life cycle of Plasmodium ovale involves two hosts: the mosquito and humans. When an infected mosquito bites a human, the parasites are injected into the skin along with the mosquito's saliva. The parasites then enter the liver where they multiply and form dormant stages called hypnozoites. After a period of time (usually several weeks to months), the hypnozoites become activated and begin to infect red blood cells, leading to the symptoms of malaria.

The symptoms of ovale malaria are similar to those of other forms of malaria and include fever, chills, headache, muscle and joint pain, and fatigue. However, ovale malaria is less likely to cause severe complications or death than falciparum malaria. Diagnosis of ovale malaria is typically made through microscopic examination of blood smears or by using rapid diagnostic tests (RDTs) that detect parasite antigens in the blood. Treatment usually involves the use of antimalarial drugs such as chloroquine or primaquine.

Immunization is defined medically as the process where an individual is made immune or resistant to an infectious disease, typically through the administration of a vaccine. The vaccine stimulates the body's own immune system to recognize and fight off the specific disease-causing organism, thereby preventing or reducing the severity of future infections with that organism.

Immunization can be achieved actively, where the person is given a vaccine to trigger an immune response, or passively, where antibodies are transferred to the person through immunoglobulin therapy. Immunizations are an important part of preventive healthcare and have been successful in controlling and eliminating many infectious diseases worldwide.

Synthetic vaccines are artificially produced, designed to stimulate an immune response and provide protection against specific diseases. Unlike traditional vaccines that are derived from weakened or killed pathogens, synthetic vaccines are created using synthetic components, such as synthesized viral proteins, DNA, or RNA. These components mimic the disease-causing agent and trigger an immune response without causing the actual disease. The use of synthetic vaccines offers advantages in terms of safety, consistency, and scalability in production, making them valuable tools for preventing infectious diseases.

Insect bites and stings refer to the penetration of the skin by insects, such as mosquitoes, fleas, ticks, or bees, often resulting in localized symptoms including redness, swelling, itching, and pain. The reaction can vary depending on the individual's sensitivity and the type of insect. In some cases, systemic reactions like anaphylaxis may occur, which requires immediate medical attention. Treatment typically involves relieving symptoms with topical creams, antihistamines, or in severe cases, epinephrine. Prevention measures include using insect repellent and protective clothing.

"Achyranthes" is a genus of plants in the family Amaranthaceae, which includes around 50 to 60 species. These plants are native to tropical and subtropical regions around the world, including Africa, Asia, Australia, and the Americas. Some common names for these plants include "devil's horsewhip," "prickly chaff flower," and "aparami."

In a medical context, certain species of Achyranthes have been used in traditional medicine in various parts of the world. For example, Achyranthes aspera has been used in Ayurvedic medicine to treat a variety of conditions, including skin diseases, respiratory disorders, and gastrointestinal complaints. Similarly, Achyranthes bidentata has been used in traditional Chinese medicine to treat arthritis, anemia, and kidney disease.

However, it's important to note that the use of these plants in traditional medicine does not necessarily mean that they are effective or safe for treating medical conditions. More research is needed to determine the safety and efficacy of Achyranthes species for medicinal purposes.

C57BL/6 (C57 Black 6) is an inbred strain of laboratory mouse that is widely used in biomedical research. The term "inbred" refers to a strain of animals where matings have been carried out between siblings or other closely related individuals for many generations, resulting in a population that is highly homozygous at most genetic loci.

The C57BL/6 strain was established in 1920 by crossing a female mouse from the dilute brown (DBA) strain with a male mouse from the black strain. The resulting offspring were then interbred for many generations to create the inbred C57BL/6 strain.

C57BL/6 mice are known for their robust health, longevity, and ease of handling, making them a popular choice for researchers. They have been used in a wide range of biomedical research areas, including studies of cancer, immunology, neuroscience, cardiovascular disease, and metabolism.

One of the most notable features of the C57BL/6 strain is its sensitivity to certain genetic modifications, such as the introduction of mutations that lead to obesity or impaired glucose tolerance. This has made it a valuable tool for studying the genetic basis of complex diseases and traits.

Overall, the C57BL/6 inbred mouse strain is an important model organism in biomedical research, providing a valuable resource for understanding the genetic and molecular mechanisms underlying human health and disease.

An epitope is a specific region on an antigen (a substance that triggers an immune response) that is recognized and bound by an antibody or a B-lymphocyte (a type of white blood cell that produces antibodies). Epitopes are also sometimes referred to as antigenic determinants.

B-lymphocytes, or B cells, are a type of immune cell that plays a key role in the humoral immune response. They produce and secrete antibodies, which are proteins that recognize and bind to specific epitopes on antigens. When a B cell encounters an antigen, it binds to the antigen at its surface receptor, which recognizes a specific epitope on the antigen. This binding activates the B cell, causing it to divide and differentiate into plasma cells, which produce and secrete large amounts of antibody that is specific for the epitope on the antigen.

The ability of an antibody or a B cell to recognize and bind to a specific epitope is determined by the structure of the variable region of the antibody or B cell receptor. The variable region is made up of several loops of amino acids, called complementarity-determining regions (CDRs), that form a binding site for the antigen. The CDRs are highly variable in sequence and length, allowing them to recognize and bind to a wide variety of different epitopes.

In summary, an epitope is a specific region on an antigen that is recognized and bound by an antibody or a B-lymphocyte. The ability of an antibody or a B cell to recognize and bind to a specific epitope is determined by the structure of the variable region of the antibody or B cell receptor.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Insect vectors are insects that transmit disease-causing pathogens (such as viruses, bacteria, parasites) from one host to another. They do this while feeding on the host's blood or tissues. The insects themselves are not infected by the pathogen but act as mechanical carriers that pass it on during their bite. Examples of diseases spread by insect vectors include malaria (transmitted by mosquitoes), Lyme disease (transmitted by ticks), and plague (transmitted by fleas). Proper prevention measures, such as using insect repellent and reducing standing water where mosquitoes breed, can help reduce the risk of contracting these diseases.

Immunoglobulins, also known as antibodies, are proteins produced by the immune system to recognize and neutralize foreign substances like pathogens or antigens. The term "immunoglobulin isotypes" refers to the different classes of immunoglobulins that share a similar structure but have distinct functions and properties.

There are five main isotypes of immunoglobulins in humans, namely IgA, IgD, IgE, IgG, and IgM. Each isotype has a unique heavy chain constant region (CH) that determines its effector functions, such as binding to Fc receptors, complement activation, or protection against pathogens.

IgA is primarily found in external secretions like tears, saliva, and breast milk, providing localized immunity at mucosal surfaces. IgD is expressed on the surface of B cells and plays a role in their activation and differentiation. IgE is associated with allergic responses and binds to mast cells and basophils, triggering the release of histamine and other mediators of inflammation.

IgG is the most abundant isotype in serum and has several subclasses (IgG1, IgG2, IgG3, and IgG4) that differ in their effector functions. IgG can cross the placenta, providing passive immunity to the fetus. IgM is the first antibody produced during an immune response and is primarily found in the bloodstream, where it forms large pentameric complexes that are effective at agglutination and complement activation.

Overall, immunoglobulin isotypes play a crucial role in the adaptive immune response, providing specific and diverse mechanisms for recognizing and neutralizing foreign substances.

The spleen is an organ in the upper left side of the abdomen, next to the stomach and behind the ribs. It plays multiple supporting roles in the body:

1. It fights infection by acting as a filter for the blood. Old red blood cells are recycled in the spleen, and platelets and white blood cells are stored there.
2. The spleen also helps to control the amount of blood in the body by removing excess red blood cells and storing platelets.
3. It has an important role in immune function, producing antibodies and removing microorganisms and damaged red blood cells from the bloodstream.

The spleen can be removed without causing any significant problems, as other organs take over its functions. This is known as a splenectomy and may be necessary if the spleen is damaged or diseased.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Drug resistance, also known as antimicrobial resistance, is the ability of a microorganism (such as bacteria, viruses, fungi, or parasites) to withstand the effects of a drug that was originally designed to inhibit or kill it. This occurs when the microorganism undergoes genetic changes that allow it to survive in the presence of the drug. As a result, the drug becomes less effective or even completely ineffective at treating infections caused by these resistant organisms.

Drug resistance can develop through various mechanisms, including mutations in the genes responsible for producing the target protein of the drug, alteration of the drug's target site, modification or destruction of the drug by enzymes produced by the microorganism, and active efflux of the drug from the cell.

The emergence and spread of drug-resistant microorganisms pose significant challenges in medical treatment, as they can lead to increased morbidity, mortality, and healthcare costs. The overuse and misuse of antimicrobial agents, as well as poor infection control practices, contribute to the development and dissemination of drug-resistant strains. To address this issue, it is crucial to promote prudent use of antimicrobials, enhance surveillance and monitoring of resistance patterns, invest in research and development of new antimicrobial agents, and strengthen infection prevention and control measures.

The liver is a large, solid organ located in the upper right portion of the abdomen, beneath the diaphragm and above the stomach. It plays a vital role in several bodily functions, including:

1. Metabolism: The liver helps to metabolize carbohydrates, fats, and proteins from the food we eat into energy and nutrients that our bodies can use.
2. Detoxification: The liver detoxifies harmful substances in the body by breaking them down into less toxic forms or excreting them through bile.
3. Synthesis: The liver synthesizes important proteins, such as albumin and clotting factors, that are necessary for proper bodily function.
4. Storage: The liver stores glucose, vitamins, and minerals that can be released when the body needs them.
5. Bile production: The liver produces bile, a digestive juice that helps to break down fats in the small intestine.
6. Immune function: The liver plays a role in the immune system by filtering out bacteria and other harmful substances from the blood.

Overall, the liver is an essential organ that plays a critical role in maintaining overall health and well-being.

"Plasmodium cynomolgi" is a species of protozoan parasite belonging to the genus Plasmodium, which causes malaria in certain primates. It's primarily found in macaque monkeys in Southeast Asia and is transmitted through the bite of infected mosquitoes.

While it mainly affects non-human primates, it can occasionally infect humans through a process called zoonosis. In rare cases, it can cause mild to severe malaria-like symptoms in humans, similar to those caused by Plasmodium vivax or Plasmodium falciparum, the species that commonly infect humans.

The life cycle of Plasmodium cynomolgi involves two hosts: the mosquito and the primate. The parasite reproduces asexually in the liver cells and red blood cells of the infected host, leading to the characteristic symptoms of malaria such as fever, chills, anemia, and splenomegaly (enlarged spleen).

Research on Plasmodium cynomolgi is important for understanding the biology and epidemiology of malaria parasites, as well as for developing new strategies for preventing and treating this widespread infectious disease.

Rodent-borne diseases are infectious diseases transmitted to humans (and other animals) by rodents, their parasites or by contact with rodent urine, feces, or saliva. These diseases can be caused by viruses, bacteria, fungi, or parasites. Some examples of rodent-borne diseases include Hantavirus Pulmonary Syndrome, Leptospirosis, Salmonellosis, Rat-bite fever, and Plague. It's important to note that rodents can also cause allergic reactions in some people through their dander, urine, or saliva. Proper sanitation, rodent control measures, and protective equipment when handling rodents can help prevent the spread of these diseases.

A schizont is a stage in the life cycle of certain parasites, particularly those that cause malaria. It refers to the stage where the parasite undergoes multiple divisions within the host cell, creating many daughter cells. This typically occurs inside red blood cells in the human body, after the parasite has been transmitted through the bite of an infected mosquito. The term "schizont" is often used in descriptions of the Plasmodium species, which are the malaria-causing protozoans.

Blood is the fluid that circulates in the body of living organisms, carrying oxygen and nutrients to the cells and removing carbon dioxide and other waste products. It is composed of red and white blood cells suspended in a liquid called plasma. The main function of blood is to transport oxygen from the lungs to the body's tissues and carbon dioxide from the tissues to the lungs. It also transports nutrients, hormones, and other substances to the cells and removes waste products from them. Additionally, blood plays a crucial role in the body's immune system by helping to fight infection and disease.

"Plasmodium gallinaceum" is not a medical term per se, but it is a scientific name used in the field of parasitology. It refers to a species of protozoan parasites that belong to the genus Plasmodium, which are known to cause malaria in birds, particularly chickens and turkeys.

The life cycle of "Plasmodium gallinaceum" involves two hosts: an Anopheles mosquito vector and a bird host. When an infected mosquito bites a bird, the parasites enter the bloodstream and infect the red blood cells, where they multiply and cause damage, leading to symptoms of malaria in the bird host.

While "Plasmodium gallinaceum" is not a human pathogen, research on this species has contributed significantly to our understanding of the biology and epidemiology of Plasmodium parasites, including those that cause malaria in humans.

Parasitic sensitivity tests, also known as parasite drug susceptibility tests, refer to laboratory methods used to determine the effectiveness of specific antiparasitic medications against a particular parasitic infection. These tests help healthcare providers identify which drugs are most likely to be effective in treating an individual's infection and which ones should be avoided due to resistance or increased risk of side effects.

There are several types of parasitic sensitivity tests, including:

1. In vitro susceptibility testing: This involves culturing the parasite in a laboratory setting and exposing it to different concentrations of antiparasitic drugs. The growth or survival of the parasite is then observed and compared to a control group that was not exposed to the drug. This helps identify the minimum inhibitory concentration (MIC) of the drug, which is the lowest concentration required to prevent the growth of the parasite.
2. Molecular testing: This involves analyzing the genetic material of the parasite to detect specific mutations or gene variations that are associated with resistance to certain antiparasitic drugs. This type of testing can be performed using a variety of methods, including polymerase chain reaction (PCR) and DNA sequencing.
3. Phenotypic testing: This involves observing the effects of antiparasitic drugs on the growth or survival of the parasite in a laboratory setting. For example, a parasite may be grown in a culture medium and then exposed to different concentrations of a drug. The growth of the parasite is then monitored over time to determine the drug's effectiveness.

Parasitic sensitivity tests are important for guiding the treatment of many parasitic infections, including malaria, tuberculosis, and leishmaniasis. These tests can help healthcare providers choose the most effective antiparasitic drugs for their patients, reduce the risk of drug resistance, and improve treatment outcomes.

Three subspecies are recognised: Plasmodium yoelii killicki Plasmodium yoelii nigeriensis Plasmodium yoelii yoelli P. yoelii ... Plasmodium yoelii is a parasite of the genus Plasmodium subgenus Vinckeia. As in all Plasmodium species, P. yoelii has both ... Wikimedia Commons has media related to Plasmodium yoelii. Information about the genome and genes of P. yoelii www.genedb.org/ ... Harupa, Anke; Sack, Brandon; Lashmanan, Viswanathan (2014). "SSP3 Is a Novel Plasmodium yoelii Sporozoite Surface Protein with ...
Interactions between malaria (Plasmodium yoelii) and leishmaniasis (Leishmania mexicana amazonensis), with a note on the blood- ... Coleman, Russell Edward, "Interactions between malaria (Plasmodium yoelii) and leishmaniasis (Leishmania mexicana amazonensis ...
... to the regulation of erythrocyte maturation and thereby affects the frequency of target cells for rodent Plasmodium yoelii ... yoelii infection.. (A) As therapeutic approach, C57BL/6 mice were infected with P. yoelii on day 0 and treated with 750 µg ... Here, using the nonlethal rodent Plasmodium strain P. yoelii 17XNL as murine malaria model, we evaluated how Ac ablation and ... P. yoelii infection. Request a detailed protocol Cryopreserved P. yoelii 17XNL-infected red blood cells (iRBCs) were passaged ...
Our study shows that drug-resistant P. yoelii NSM has an impact on the transcript abundance levels of An.stephensi mostly ... To study the impact of drug-resistant Plasmodium infections on An. stephensi gene transcription, we analyzed the three major ... To understand the differential gene expression in Anopheles following infection with drug-resistant Plasmodium, we conducted a ... genes of the drug-resistant Plasmodium in the mosquito and the different transmission patterns of drug-resistant Plasmodium by ...
gi,23478252,gb,EAA15388.1, cyclophilin [Plasmodium yoelii yoelii]. Match: gi,5911377,gb,AAD55769.1,. score: 222.6. e-value: 7e- ... gi,5911377,gb,AAD55769.1, cyclophilin [Plasmodium falciparum]. Match: gi,23612960,ref,NP_704499.1,. score: 221.9. e-value: 1.2e ... gi,23612960,ref,NP_704499.1, peptidyl-prolyl cis-trans isomerase precursor [Plasmodium falciparum 3D7] gi,23499238,em.... ...
Plasmodium yoelii nigeriensis Biological Process. sporozoan zygote development Cellular Component. cyst wall Colorized scanning ... Plasmodium yoelii nigeriensis) oocysts ( thick-walled structure in which sporozoan zygotes develop) developing on the midgut ...
Plasmodium yoelii yoelii]. Match: gi,34877759,ref,XP_240364.2,. score: 422.9. e-value: 7e-117. Identity: 63.43%. Span: 924bp ( ... gi,23619052,ref,NP_705014.1, clathrin-adaptor medium chain, putative [Plasmodium falciparum 3D7] gi,23615259,emb,CAD5.... ... gi,23508393,ref,NP_701062.1, clathrin coat assembly protein, putative [Plasmodium falciparum 3D7] gi,23496125,gb,AAN3.... ...
... are frequently observed in patients with Plasmodium falciparum malaria. However, the correlation between malaria intestinal ... Concurrent infection with Heligmosomoides polygyrus suppresses anti-Plasmodium yoelii protection partially by induction of CD4 ... Plasmodium berghei ANKA causes intestinal malaria associated with dysbiosis. Sci. Rep. 5, 15699; doi: 10.1038/srep15699 (2015). ... Accumulation of Plasmodium berghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in ...
Immunization with the MAEBL M2 Domain Protects against Lethal Plasmodium yoelii Infection  Leite, Juliana A. et al. , Date ... Rosettes integrity protects Plasmodium vivax of being phagocytized  Albrecht, Letusa et al. , Date Issued: 2020 ...
In the mouse parasite Plasmodium yoelii, only the last two genes in the canonical pathway, PyPPAT and PyDPCK, are essential for ... Figure 1. CoA metabolism in the host and in Plasmodium spp.: Substrates, biosynthesis pathway, and regulation. Plasmodium can ... Figure 1. CoA metabolism in the host and in Plasmodium spp.: Substrates, biosynthesis pathway, and regulation. Plasmodium can ... Hart, R.J.; Lawres, L.; Fritzen, E.; Mamoun, C.B.; Aly, A.S.I. Plasmodium yoelii vitamin B5 pantothenate transporter candidate ...
Description: Plasmodium Yoelii Translation factor GUF1 homolog, mitochondrial protein, partial, recombinant protein. ... Description: Plasmodium Yoelii tRNA-splicing ligase RtcB homolog protein, partial, recombinant protein. ... Description: Plasmodium Yoelii Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial protein, partial, recombinant ... Description: Plasmodium Yoelii Calcium-dependent protein kinase 1 protein, partial, recombinant protein. ...
A novel Plasmodium yoelii pseudokinase, PypPK1, is involved in erythrocyte invasion and exflagellation center formation. ...
2003) Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity Nature Medicine 9:93- ... 2018) A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum Nature ... 2015) Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice Cell Host & Microbe 17: ... 2016) Global epidemiology of Plasmodium vivax The American Journal of Tropical Medicine and Hygiene 95:15-34. ...
Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. NatureNature. 419* ... Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. NatureNature. 419* ... Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. NatureNature. 419* ... Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. NatureNature. 419* ...
Ultrastructural study on effect of primaquine on sporogonic stage of Plasmodium yoelii nigeriensis Pages (282-284) Yun-lin Shi ...
Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature. 2002 Oct 3;419( ... Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa. Nat ... Plasmodium falciparum field isolates from areas of repeated emergence of drug resistant malaria show no evidence of ... Protection against Plasmodium falciparum malaria by PfSPZ Vaccine. JCI Insight. 2017 Jan 12;2(1):e89154. PubMed PMID: 28097230. ...
... proteins from Plasmodium parasites, and identifies a PfRH5 sequence variant that can be used for clinical production of a non- ... The Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) has recently emerged as a leading candidate antigen ... of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a ... While Plasmodium parasites rarely attach N-linked glycans to proteins46, insect and mammalian cells tend to attach large and ...
"The antiplasmodial effect of the extracts and formulated capsules of Phyllanthus amarus on Plasmodium yoelii infection in mice ...
Jarjour, N. N., Schwarzkopf, E. A., Bradstreet, T. R., Shchukina, I., Lin, C. C., Huang, S. C. C., Lai, C. W., Cook, M. E., Taneja, R., Stappenbeck, T. S., Randolph, G. J., Artyomov, M. N., Urban, J. F. & Edelson, B. T., Jun 1 2019, In: Nature immunology. 20, 6, p. 687-700 14 p.. Research output: Contribution to journal › Article › peer-review ...
10/01/2004 - "Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances ... 08/01/2011 - "High antibody levels directed to Plasmodium falciparum merozoite surface proteins (MSP), including MSP2, as well ...
... and Plasmodium yoelii [41-44] are well established. With c-NHEJ pathways absent from Plasmodium, CRISPR/Cas9 gene editing ... Generation and functional characterisation of Plasmodium yoelii csp deletion mutants using a microhomology-based CRISPR/Cas9 ... Ribozyme-mediated, multiplex CRISPR gene editing and CRISPR interference (CRISPRi) in rodent-infectious Plasmodium yoelii ... CRISPR/cas9 mediated sequential editing of genes critical for ookinete motility in Plasmodium yoelii ...
Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature. 2002;419:512- ... P. berghei and P. yoelii (both rodent Plasmodia) are commonly used for in vivo studies as these species share important ... As an alternative to human Plasmodium studies in monkeys, researchers recently focused on close simian Plasmodium spp in NHP: P ... Nevertheless, even in murine Plasmodium species that share some features with human Plasmodium, the ability to interpret and ...
Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against ... Accumulation of Plasmodium-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice., ... Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection., Liehl P, Zuzarte-Luís V, Chan J, ... Regulatory CD4+ CD25+ Foxp3+ T cells expand during experimental Plasmodium infection but do not prevent cerebral malaria, ...
At present, although artemisinin-resistant strains of P. falciparum (Inselburg, 1985) and Plasmodium yoelii (Peters and ... In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia. American ... Plasmodium vivax resistance to chloroquine? Lancet 2(8673):1183-1184.. Sabchareon A, Attanath P, Chanthavanich P, Phanuaksook P ... Among the species of Plasmodium that infect humans, only P. vivax and P. ovale have latent liver hypnozoites that can trigger a ...
Erin Vrana - Assessing the Expression and Vaccine Candidate Potential of UIS12 in Plasmodium yoelii ... Erin Vavra, First Place - Characterization of the Role of UIS12 in Plasmodium yoelii Male Gametocyte Activation ... Steven Griffin, "Determining Regulatory Proteins of the P25 Transcript in Plasmodium Yoelli" ... 0420300 as a Potential Drug Target in the Malaria Inducing Parasite Plasmodium falciparum ...
Using Anopheles stephensi and Plasmodium yoelii as a model system, we demonstrate that mosquitoes with early stage infections ( ... Our results support the hypothesis that the feeding behaviour of female mosquitoes is altered by Plasmodium, but question the ... Previous studies have suggested that Plasmodium parasites can manipulate mosquito feeding behaviours such as probing, ...
Equivalent antiplasmodial activity was found for NQ in male and female mice infected with P. yoelii. This study will be helpful ... yoelii, compared with female mice (ED90, 1.67 mg/kg). The binding rates of NQ to plasma protein were similar in males and ... The antiplasmodial efficacy of NQ was studied in male or female mice infected with Plasmodium yoelii. The recrudescence and ... Table 2 Antiplasmodial activity of naphthoquine (NQ) in male and female mice infected with Plasmodium yoelii. Full size table. ...
Moreover, it can be effectively applied to both human (Plasmodium falciparum, Plasmodium vivax) and rodent (Plasmodium yoelii) ... Moreover, it can be effectively applied to both human (Plasmodium falciparum, Plasmodium vivax) and rodent (Plasmodium yoelii) ... Moreover, it can be effectively applied to both human (Plasmodium falciparum, Plasmodium vivax) and rodent (Plasmodium yoelii) ... Moreover, it can be effectively applied to both human (Plasmodium falciparum, Plasmodium vivax) and rodent (Plasmodium yoelii) ...
... nanoparticles conjugated to chloroquine reached the blood circulation and cured Plasmodium yoelii-infected mice, slightly ... JTD Keywords: carriers, drug-delivery, efficacy, heparin, malaria, mosquito, nanocarriers, parasite, plasmodium, targeted drug ... JTD Keywords: Anopheles, Antimalarial drugs, Heparin, Malaria, Mosquitoes, Nanomedicine, Nanotechnology, Plasmodium, Targeted ... Fernàndez-Busquets, X., (2016). Novel strategies for Plasmodium-targeted drug delivery Expert Opinion on Drug Delivery , 13, (7 ...

No FAQ available that match "plasmodium yoelii"

No images available that match "plasmodium yoelii"